The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Study reveals that sleep traits predict over 15% of body characteristics across 15 physiological systems, with visceral fat, ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

Menopause is a significant phase in women's health, in which the incidence of obstructive sleep apnea (OSA) is significantly increased. Body fat distribution changes with age and hormone levels in ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Sleepiness at the wheel is a significant contributing factor to motor vehicle accidents. A new analysis published in ...

The pathophysiology of residual sleepiness in treated obstructive sleep apnoea (OSA) remains poorly understood. Animal models ...

There are two types of sleep apnea: Obstructive sleep apnea (OSA) causes the upper airway to collapse briefly and temporarily pause breathing. The most common cause of obstructive apnea is obesity.

The two most commonly recognized types of sleep apnea are obstructive and central sleep ... cycles of reduced or stopped breathing (hypopnea) and increased breathing (hyperpnea).

They deliver air through a mask. Continuous positive airway pressure devices treat moderate to severe obstructive sleep apnea. They give you constant air pressure to keep your breathing passages ...